Taken together, these data suggest that TLR3 signaling cascades upregulate Ro52 and induce apoptosis of salivary epithelium, thereby releasing autoantigens that drive immune hyperactivity in SS. This evidence concerns the gene TLR3 and synovial sarcoma.